Folate and cancer : a review of the literatureGLYNN, S. A; ALBANES, D.Nutrition and cancer. 1994, Vol 22, Num 2, pp 101-119, issn 0163-5581Article

Do blood donors read and understand screening educational materials?RUGEGE-HAKIZA, S. E; GLYNN, S. A; HUTCHING, S. T et al.Transfusion (Philadelphia, PA). 2003, Vol 43, Num 8, pp 1075-1083, issn 0041-1132, 9 p.Article

Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donorsWANG, B; HIGGINS, M. J; KLEINMAN, S et al.Transfusion (Philadelphia, PA). 2004, Vol 44, Num 8, pp 1243-1251, issn 0041-1132, 9 p.Article

Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob diseaseBUSCH, M. P; GLYNN, S. A; SCHREIBER, G. B et al.Transfusion (Philadelphia, PA). 1997, Vol 37, Num 10, pp 996-1002, issn 0041-1132Article

The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistanceTONER, A. P; MCLAUGHLIN, F; GLYNN, S. A et al.British journal of cancer. 2013, Vol 109, Num 8, pp 2131-2141, issn 0007-0920, 11 p.Article

Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemicTOBLER, L. H; BIANCO, C; SMITH, D et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 4, pp 480-486, issn 0041-1132, 7 p.Article

Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections : a comparison of apheresis and whole-blood donorsGLYNN, S. A; SCHREIBER, G. B; BUSCH, M. P et al.Transfusion (Philadelphia, PA). 1998, Vol 38, Num 4, pp 350-358, issn 0041-1132Article

Risk factors for hepatitis C virus infection in United States blood donorsMURPHY, E. L; BRYZMAN, S. M; NEAL, K. R et al.Hepatology (Baltimore, Md.). 2000, Vol 31, Num 3, pp 756-762, issn 0270-9139Article

Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donorsMURPHY, E. L; GLYNN, S. A; SCHREIBER, G. B et al.The Journal of infectious diseases. 1997, Vol 176, Num 6, pp 1468-1475, issn 0022-1899Article

Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in united states blood donors?BAOGUANG WANG; SCHREIBER, G. B; GLYNN, S. A et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 7, pp 1089-1096, issn 0041-1132, 8 p.Article

The RADAR repository : a resource for studies of infectious agents and their transmissibility by transfusionKLEINMAN, S. H; GLYNN, S. A; KING, M. R et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 7, pp 1073-1083, issn 0041-1132, 11 p.Article

Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donorsPELLETT, P. E; WRIGHT, D. J; NEIPEL, F et al.Transfusion (Philadelphia, PA). 2003, Vol 43, Num 9, pp 1260-1268, issn 0041-1132, 9 p.Article

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996GLYNN, S. A; KLEINMAN, S. H; SCHREIBER, G. B et al.JAMA, the journal of the American Medical Association. 2000, Vol 284, Num 2, pp 229-235, issn 0098-7484Article

Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cellsDOWLING, P; MAURYA, P; MELEADY, P et al.Anticancer research. 2007, Vol 27, Num 3A, pp 1309-1317, issn 0250-7005, 9 p.Conference Paper

Prevalence of transfusion-transmissible viral infections in first-time US blood donors by donation siteWANG, B; SCHREIBER, G. B; GLYNN, S. A et al.Transfusion (Philadelphia, PA). 2003, Vol 43, Num 6, pp 705-712, issn 0041-1132, 8 p.Article

Laboratory abnormalities in former blood donors seropositive for human T-lymphotropic virus types 1 and 2 : A prospective analysisGLYNN, S. A; MURPHY, E. L; WRIGHT, D. J et al.Archives of pathology & laboratory medicine (1976). 2000, Vol 124, Num 4, pp 550-555, issn 0363-0153Article

Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donorsMURPHY, E. L; GLYNN, S. A; FRIDEY, J et al.Archives of internal medicine (1960). 1999, Vol 159, Num 13, pp 1485-1491, issn 0003-9926Article